The effect of risedronate on posterior lateral spinal fusion in a rat model

Journal of Korean Neurosurgical Society

Volumn 46, Issue 1, 2009, Pages 45-51

  Gezici, Ali Riza ^a   Ergün, Rüçhan ^a   Gürel, Kamil ^a   Yilmaz, Fahri ^a   Okay, Önder ^b   Bozdogan, Ömer ^a  

^a ABANT IZZET BAYSAL UNIVERSITY   (Turkey)

^b ANKARA NUMUNE HOSPITAL   (Turkey)

Author keywords

Rats; Risedronate; Spinal fusion; Spine

Indexed keywords

RISEDRONIC ACID;

ALLOGRAFT; ANESTHESIA INDUCTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOGRAFT; BONE DENSITY; CONTROLLED STUDY; DRUG ACTIVITY; DRUG BIOAVAILABILITY; DRUG ELIMINATION; LUMBAR VERTEBRA; NONHUMAN; OSTEOBLAST; OSTEOCLAST; POSTOPERATIVE PERIOD; RADIOLOGICAL PARAMETERS; RAT; SPINE FUSION; SPRAGUE DAWLEY RAT;

EID: 73349083719     PISSN: 20053711     EISSN: 15987876     Source Type: Journal    
DOI: 10.3340/jkns.2009.46.1.45     Document Type: Article

References (47)

1. Bae DC, Stein BS : The diagnosis and treatment of osteoporosis in men on androgen deprivation therapy for advanced carcinoma of the prostate. J Urol 172 : 2137-2144, 2004
2. Berenson JR, Lichtenstein A, Porter L, Dimopoulos MA, Bordoni R, George S, et al : Efficacy of pamidronate in reducing skeletal events in patients with advanced multiple myeloma. Myeloma Aredia Study Group. N Engl J Med 334 : 488-493, 1996
3. Blake GM, Fogelman I : Bone densitometry, steroids and osteoporosis. Curr Opin Nephrol Hypertens 11 : 641-647, 2002
4. Boden SD, Schimandle JH, Hutton WC : An experimental lumbar intertransverse process spinal fusion model. Radiographic, histologic, and biomechanical healing characteristics. Spine (Phila Pa 1976) 20 : 412-420, 1995
5. Boden SD : The biology of posterolateral lumbar spinal fusion. Orthop Clin North Am 29 : 603-619, 1998
6. Boden SD : Overview of the biology of lumbar spine fusion and principles for selecting a bone graft substitute. Spine (Phila Pa 1976) 27 : S26-S31, 2002
7. Boonen S, Haentjens P, Vandenput L, Vanderschueren D : Preventing osteoporotic fractures with antiresorptive therapy : implications of microarchitectural changes. J Intern Med 255 : 1-12, 2004
8. Colterjohn NR, Bednar DA : Procurement of bone graft from the iliac crest. An operative approach with decreased morbidity. J Bone Joint Surg Am 79 : 756-759, 1997
9. Choi Y, Oldenburg FP, Sage L, Johnstone B, Yoo JU : A bridging demineralized bone implant facilitates posterolateral lumbar fusion in New Zealand white rabbits. Spine (Phila Pa 1976) 32 : 36-41, 2007
10. Cotler JM, Star AM : Complications of spinal fusion in Cotler JM, Cotler HM (eds) : Spinal fusion : Science and Technique. Springer-Verlag, New York, 1990, pp 361-387
11. Das H, Wang L, Kamath A, Bukowski JF: Vgamma2Vdelta2 T-cell receptor-mediated recognition of aminobisphonates. Blood 98 : 1616-1618, 2001
12. Delmas PD : Treatment of postmenopausal osteoporosis. Lancet 359 : 2018-2026, 2002
13. Emery SE, Brazinski MS, Koka A, Bensusan JS, Stevenson S : The biological and biomechanical effects of irradiation on anterior spinal bone grafts in a canine model. J Bone Joint Surg Am 76 : 540-548, 1994
14. Erben RG, Mosekilde L, Thomsen JS, Weber K, Stahr K, Leyshon A, et al. : Prevention of bone loss in ovariectomized rats by combined treatment with risedronate and 1alpha, 25-dihydroxyvitamin D3. J Bone Miner Res 17 : 1498-1511, 2002
15. Feiertag MA, Boden SD, Schimandle JH, Norman JT : A rabbit model for nonunion of lumbar intertransverse process spine arthrodesis. Spine (Phila Pa 1976) 21 : 27-31, 1996
16. Fless JL : Statistical methods for rates and proportion, ed 2. New York : Jon Wiley & Sons, 1981
17. Gertz BJ, Holland SD, Kline WF, Matuszewski BK, Porras AG : Clinical pharmacology of alendronate sodium. Osteoporos Int 3 Suppl 3 : S13-16, 1993
18. Harris ST, Watts NB, Genant HK, McKeever CD, Hangartner T, Keller M, et al. : Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmanopausal osteoporosis : a randomized controlled trial. Vertebral Efficacy with Risedronate Therapy (VERT) Study Group. JAMA 282 : 1344-1352, 1999
19. Hill NM, Horne JG, Devane PA : Donor site morbidity in the iliac crest bone graft. Aust N Z J Surg 69 : 726-728, 1999
20. Hoard MA, Bill TJ, Campbell RL : Reduction in morbidity after iliac crest bone harvesting : the concept of preemptive analgesia. J Craniofac Surg 9 : 448-451, 1998
21. Huang RC, Khan SN, Sandhu HS, Metzl JA, Cammisa FP Jr, Zheng F, et al. : Alendronate inhibits spine fusion in a rat model. Spine (Phila Pa 1976) 30 : 2516-2522, 2005
22. Itoh H, Ebara S, Kamimura M, Tateiwa Y, Kinoshita T, Yuzawa Y, et al. : Experimental spinal fusion with use of recombinant human bone morphogenetic protein 2 Spine 24 : 1402-1405, 1999
23. Iwamoto J, Takeda T, Sato Y, Shen CL, Yeh JK : Beneficial effect of pretreatment and treatment continuation with risedronate and vitamin K2 on cancellous bone loss after ovariectomy in rats : a bone histomorphometry study. J Nutr Sci Vitaminol (Tokyo) 52 : 307-315, 2006
24. Iwamoto J, Seki A, Takeda T, Sato Y, Yamada H, Yeh JK : Effect of risedronate on the corticol and cancellous bone mass and mechanical properties ovariectomized rats : a comparison with the effects of alfacalcidol. J Nutr Sci Vitaminol (Tokyo) 52 : 393-401, 2006
25. Kaynak D, Meffert R, Günhan M, Günhan O, Ozkaya O : A histopathological investigation on the effects of the bisphosphonate alendronate on resorptive phase following mucoperiosteal flap surgery in the mandible of rats. J Periodontol 71 : 790-796, 2000
26. Lehman RA Jr, Kuklo TR, Freedman BA, Cowart JR, Mense MG, Riew KD : The effect of alendronate sodium on spinal fusion : a rabbit model. Spine J 4 : 36-43, 2004
27. Long J, Lewis S, Kuklo T, Zhu Y, Riew KD : The effect of cyclooxygenase-2 inhibitors on spinal fusion. J Bone Joint Surg Am 84-A : 1763-1768, 2002
28. McCloskey EV, MacLennan IC, Drayson MT, Chapman C, Dunn J, Kanis JA : A randomized trial of the effect of clodronate on skeletal morbidity in multiple myeloma. MRC Working Party on Leukaemia in Adults. Br J Haematol 100 : 317-325, 1998
29. Mitchell DY, Barr WH, Eusebio RA, Stevans KA, Duke FP, Russell DA, et al. : Risedronate pharmacokinetics and intra- and inter-subject variability upon single-dose intravenous and oral administration. Pharm Res 18 : 166-170, 2001
30. Morris TH : Dose estimation among species in Leary SL (ed) : Formulary for Laboratory Animals, ed 2. Ames, IA : Iowa State Press, 1999, pp 3-14
31. Mundy GR, Yoneda T, Hiraga T: Preclinical studies with zolendronic acid and other bisphosphonates: impact on the bone microenvironment. Semin Oncol 28 : 35-44, 2001
32. Myoung H, Park JY, Choung PH : Effects of å bisphosphonate on the expression of bonespecific genes after autogenous free bone grafting in rats. J Periodontal Res 36 : 244-251, 2001
33. Otomo H, Sakai A, Ikeda S, Tanaka S, Ito M, Phipps RJ, et al. : Regulation of mineral-to-matrix ratio of lumbar trabecular bone in ovariectomized rats treated with risedronate in combination with or without vitamin K2. J Bone Miner Metab 22 : 404-414, 2004
34. Reginster J, Minne HW, Sorensen OH, Hooper M, Roux C, Brandi ML, et al. : Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis. Vertebral Efficacy with Risedronate Therapy (VERT) Study Group. Osteoporos Int 11 : 83-91, 2000
35. Reinholz GG, Gertz B, Pederson L, Sanders ES, Subramaniam M, Ingle JN, et al. : Bisphosphonates directly regulate cell proliferation, differentiation, and gene expression in human osteoblasts. Cancer Res 60 : 6001-6007, 2000
36. Riggs BL, Hartmann LC : Selective estrogen-receptor modulators-mechanisms of action and application to clinical practice. N Engl J Med 348 : 618-629, 2003
37. Robertson PA, Wrag AC : Natural history of posterior iliac crest bone graft donation for spinal surgery : a prospective analysis of morbidity. Spine (Phila Pa 1976) 26 : 1473-1476, 2001
38. Rogers MJ, Frith JC, Luckman SP, Coxon FR, Benford HL, Mönkkönen J, et al. : Molecular mechanism of action of bisphosphonate. Bone 24 : 73S-79S, 1999
39. Sama AA, Khan SN, Myers ER, Huang RC, Cammisa FR Jr, Sandhu HS, et al. : High-dose alendronate uncouples osteoclast and osteoblast function : a study in a rat spine pseudarthrosis model. Clin Orthop Relat Res : 135-142, 2004
40. Seiler JG 3rd, Johnson J : Iliac crest autogenous bone grafting: donor site complications. J South Orthop Assoc 9 : 91-97, 2000
41. Steinmann JC, Herkowitz HN : Pseudarthrosis of the spine. Clin Orthop Relat Res : 80-90, 1992
42. Werkman C, Senra GS, Rocha RF, Brandão AA : Comparative therapeutic use of Risendronate and Calcarea phosphorica--allopathy versus homeopathy--in bone repair in castrated rats. Braz Oral Res 20 : 196-201, 2006
43. Xue Q, Li H, Zou X, Bünger M, Egund N, Lind M, et al. : The influence of alendronate treatment and bone graft volume on posterior lateral spine fusion in a porcine model. Spine (Phila Pa 1976) 30 : 1116-1121, 2005
44. Yee AJ, Bae HW, Friess D, Robbin M, Johnstone B, Yoo JU : Accuracy and interobserver agreement for determinations of rabbit posterolateral spinal fusion. Spine (Phila Pa 1976) 29 : 1308-1313, 2004
45. Yee AJ, Hyun HW, Friess D, Roth SM, Whyne C, Robbin M, et al. : The use of simvastatin in rabbit posterolateral lumbar intertransverse process spine fusion. Spine J 6 : 391-396, 2006
46. Zdeblick TA : A prospective, randomized study of lumbar fusion. Preliminary results. Spine (Phila Pa 1976) 18 : 983-991, 1993
47. Zou X, Xue Q, Li H, Bunger M, Lind M, Bünger C : Effect of alendronate on bone ingrowth into porous tantalum and carbon fiber interbody devices. : an experimental study on spinal fusion in pigs. Acta Orthop Scand 74 : 596-603, 2003